GLYBURIDE
- Product NDC
- 50090-0495
- 11-digit product format
- 500900495
- Labeler code
- 50090
- Product ID
- 50090-0495_d7312022-17ca-4251-a684-6045f7841266
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GLYBURIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA090937
- Marketing category
- ANDA
- Marketing start
- 2010-10-05
- Substance
- GLYBURIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GLYBURIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLYBURIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | SX6K58TVWC |
| Rxcui | 310537 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 50090-0495-0 | 2023-02-07 | C162847 | 48780-1 | f386c649-fc46-0266-e053-dadaa90a7c1a | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-1 | 2023-02-07 | C162847 | 48780-1 | f386c649-fc46-0266-e053-dadaa90a7c1a | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-2 | 2023-02-07 | C162847 | 48780-1 | f386c649-fc46-0266-e053-dadaa90a7c1a | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-8 | 2023-02-07 | C162847 | 48780-1 | f386c649-fc46-0266-e053-dadaa90a7c1a | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-9 | 2023-02-07 | C162847 | 48780-1 | f386c649-fc46-0266-e053-dadaa90a7c1a | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-0 | 2023-01-30 | C162847 | 48780-1 | f386c649-fc46-0266-e053-dadaa90a7c1a | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-fc46-0266-e053-dadaa90a7c1a | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-2 | 2023-01-30 | C162847 | 48780-1 | f386c649-fc46-0266-e053-dadaa90a7c1a | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-8 | 2023-01-30 | C162847 | 48780-1 | f386c649-fc46-0266-e053-dadaa90a7c1a | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-9 | 2023-01-30 | C162847 | 48780-1 | f386c649-fc46-0266-e053-dadaa90a7c1a | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-0495 | GLYBURIDE TABLET [A-S MEDICATION SOLUTIONS] | 11 | Current NDC, Legacy NDC, 5 package rows | 20230208_3c91a408-973b-4572-832f-515f61d5be1f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-0495-0 | 50090049500 | 30 TABLET in 1 BOTTLE (50090-0495-0) | 30 tablet | 2016-06-29 | 0000-00-00 | No | No | Current |
| 50090-0495-1 | 50090049501 | 100 TABLET in 1 BOTTLE (50090-0495-1) | 100 tablet | 2016-06-29 | 0000-00-00 | No | No | Current |
| 50090-0495-2 | 50090049502 | 60 TABLET in 1 BOTTLE (50090-0495-2) | 60 tablet | 2016-06-29 | 0000-00-00 | No | No | Current |
| 50090-0495-8 | 50090049508 | 200 TABLET in 1 BOTTLE (50090-0495-8) | 200 tablet | 2016-06-29 | 0000-00-00 | No | No | Current |
| 50090-0495-9 | 50090049509 | 90 TABLET in 1 BOTTLE (50090-0495-9) | 90 tablet | 2016-06-29 | 0000-00-00 | No | No | Current |